Search Results
May 26, 2026, 08:38 ET Brave Healer Productions Releases "From Burnout to Burning Bright: The Ultimate Guide to Prevention, Healing and Recovery"
Deanna Cotten, Angel Gold, Dr. Kenn L. Gold, Alysha St. Germain Heidke, Sara Jane, Guy Kilchrist, Maysha, David D. McLeod, Dr. Cora Pettipas. Dr. Oliver T. Reid, Alessio Rizzo, Karen Robinson, Susan Schiller, Dr. Ruchi Mishra Sharma, Kristina Skye, Amelia South, Dr. Ruth A. Souther, Janette Stuart, Tiffany
More news about: Brave Healer Productions
May 26, 2026, 08:12 ET MGI Tech erhält drei iF Design Awards für Durchbrüche bei Sequenzierung und Ultraschall
T1+ Desktop-Gensequenzer: Präzision neu definiertDer 2025 eingeführte T1+ ist ein Desktop-Gensequenzer, der innerhalb von 24 Stunden Daten im Terabase-Maßstab erzeugen kann. Die iF Jury würdigte den Ein-Klick-Workflow „Library-to-Report" des T1+, bei dem DNB-Vorbereitung,
More news about: MGI Tech Co., Ltd.
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
regulatory T‑cells may enhance anti‑tumor immune responses and help overcome immunotherapy resistance in these difficult‑to‑treat tumors.About LYMPHIR™ (denileukin diftitox‑cxdl)LYMPHIR is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma
More news about: Citius Oncology, Inc.
May 26, 2026, 08:00 ET LUCA MINING CORP. REPORTS STRONG FIRST QUARTER 2026 RESULTS
driven by a 45% improvement in silver head grades to 48 g/t. Copper production increased 23% to 368 thousand pounds, supported by higher copper grades.Gold production of 3,503 ounces reflected the impact of lower gold grades (1.73 g/t vs. 2.40 g/t in Q1 2025) and lower metallurgical recoveries as mine
More news about: Luca Mining Corp.
May 26, 2026, 08:00 ET Contango Commences 40,000-meter 2026 Drill Program at the Kitsault Valley Silver-Gold Project
continuity of this unique style of mineralization. Drill hole DV25-470 intersected 518 g/t Ag, 0.19% Pb and 0.34% Zn over 0.52 meters, within a wider zone of mineralization and wall rock alteration grading 66 g/t Ag, 0.12% Pb and 0.19% Zn over 12.45 meters, including the presence of native silver. This
More news about: Contango Silver & Gold Inc.
May 26, 2026, 07:30 ET Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
focused on the detection of immune responses to and diagnosis of viral diseases. The Company is developing T cell-based test technologies intended to support an immunology profiling platform. T cell testing may have applications in post-acute infection syndromes, including Long COVID, and other chronic
More news about: Virax BioLabs Group Limited
May 26, 2026, 07:30 ET Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
(SGX942). We were developing HyBryte™ (SGX301 or synthetic hypericin sodium), a photodynamic therapy utilizing visible light, for the treatment of cutaneous T-cell lymphoma (CTCL) in a Phase 3 study called "FLASH2" (Fluorescent Light Activated Synthetic Hypericin 2). The Data Monitoring Committee completed its
More news about: SOLIGENIX, INC.
May 26, 2026, 07:02 ET 1911 Gold Reports High-Grade Drill Results from Ogama-Rockland Intersecting 10.41 g/t Gold over 3.40 m, including 32.40 g/t Gold over 1.00 m
OG-18-002: Intersected 9.82 g/t Au over 3.90 m (at 347.12m downhole depth), including 100.54 g/t Au over 0.34 m OG-18-004: Intersected 2.83 g/t Au over 12.01 m (at 476.50 m downhole depth), including 6.43 g/t Au over 4.75 m, including 35.28 g/t Au over 0.34 m OG-18-002:
More news about: 1911 Gold Corporation
May 26, 2026, 07:00 ET Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors
and will investigate the safety, tolerability and preliminary efficacy of escalating doses of ADCE-T02 in combination with standard dose pembrolizumab in patients with advanced solid tumors.ADCE-T02 is currently being evaluated as a monotherapy in the Phase I Tiffany-01 (
More news about: Adcendo
May 26, 2026, 07:00 ET Adcendo ApS Announces Clinical Collaboration and Supply Agreement with MSD to Evaluate ADCE-T02 in Combination with KEYTRUDA® (Pembrolizumab) in a Phase Ib Study in Patients with Advanced Solid Tumors
and will investigate the safety, tolerability and preliminary efficacy of escalating doses of ADCE-T02 in combination with standard dose pembrolizumab in patients with advanced solid tumors.ADCE-T02 is currently being evaluated as a monotherapy in the Phase I Tiffany-01 (
More news about: Adcendo
May 26, 2026, 07:00 ET Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
contactChristine PetersT +49 160 60 66 [email protected] for analysts and investorsDr. Dominik HegerT +49 6172 609 2525
More news about: Fresenius Medical Care Holdings, Inc.
May 26, 2026, 06:30 ET GoldMining Commences 2026 Exploration Drilling Program at its Yarumalito Gold-Copper Project, Colombia
257 metres ("m") at 0.50 grams per tonne ("g/t") gold ("Au") and 0.1% copper ("Cu") from surface (YAR-06)250 m at 0.51 g/t Au and 0.13% Cu from surface (YAR-08)141.4 m at 0.77 g/t Au and 0.09% Cu from surface (YAR-11)Alastair
More news about: GoldMining Inc.
May 26, 2026, 06:30 ET Eminent Announces Positive Results from Seismic Survey at Hot Springs Range Project, Nevada
4), and provided further support for the interpreted position of the Little Humboldt Fault. The best intercept to date of 9.2 metres grading 3.2 g/t gold (
More news about: Eminent Gold Corp.
May 26, 2026, 04:50 ET Du Pakistan à Shanghai : un parcours CAR-T dans la lutte contre le lymphome récidivant
avoir subi une collecte de lymphocytes, la première étape du processus CAR-T, et des traitements préparatoires pour optimiser son état physique en vue d'une perfusion cellulaire sûre, Muhammad a reçu sa perfusion de cellules CAR-T personnalisée le 23 avril 2026. Au cours de son hospitalisation, il n'a
More news about: Jiahui Health
May 26, 2026, 04:34 ET De Pakistán a Shanghái: Un viaje de terapia CAR-T para combatir el linfoma recidivante
sometiera a la recolección de linfocitos, el primer paso del proceso CAR-T, y a terapias preparatorias para optimizar su condición física para una infusión celular segura, Muhammad recibió su infusión personalizada de células CAR-T el 23 de abril de 2026. Durante la observación hospitalaria, solo experimentó
More news about: Jiahui Health
May 26, 2026, 04:31 ET Von Pakistan nach Shanghai: Eine CAR-T-Behandlung im Kampf gegen ein rezidiviertes Lymphom
entnommen worden waren – der erste Schritt des CAR-T-Verfahrens – und er vorbereitende Therapien erhalten hatte, um seinen körperlichen Zustand für eine sichere Zellinfusion zu optimieren, erhielt Muhammad am 23. April 2026 seine personalisierte CAR-T-Zellinfusion. Während seines stationären Aufenthalts trat
More news about: Jiahui Health
May 26, 2026, 02:45 ET Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company
Start 10+ Phase 3 or pivotal studies by FY2030 5+ Phase 3 or pivotal studies by FY2027 Achieve 4.3T+ yen cumulative Core operating profit (OP) before R&D expenses Revenue from Strategic Brands doubled versus FY2025 Recurring
More news about: Astellas Pharma Inc.
May 26, 2026, 02:27 ET Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
LinkedIn.References: 1. Wijeratne T et al. Eur J Neurol. 2019;26(11):e92-e93.2. Kim, BK et al. Cephalalgia 2013;33(13):1106-16.3. Kim BK et al. J Clin Neurol. 2022
More news about: H. Lundbeck A/S
May 26, 2026, 00:35 ET Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session
innovation ecosystem centered on its Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms. Supported by a global-standard
More news about: Akeso, Inc.
May 25, 2026, 22:53 ET From the Yangtze to the Mekong: youth across borders unlock rivers' "Green Code"
https://www.jiangsunow.com/news/202605/t20260525_s6a13f2a9e4b0e575e19bf5d0.shtml
More news about: JiangsuNow
May 25, 2026, 22:53 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody. Ann Surg. 2018 Sep;268(3):488-496. doi: 10.1097/ Alelign T, Ahmed MM, Bobosha K, Tadesse Y, Howe R, Petros B. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. J
More news about: Hansa Biopharma AB
May 25, 2026, 22:52 ET Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody. Ann Surg. 2018 Sep;268(3):488-496. doi: 10.1097/ Alelign T, Ahmed MM, Bobosha K, Tadesse Y, Howe R, Petros B. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. J
More news about: Hansa Biopharma AB
May 25, 2026, 15:00 ET In HelloNation, Cremation Services Expert Matthew T. Cup Explains Why Cost Transparency Matters During Cremation Planning
a HelloNation article, Cremation Services Expert Matthew T. Cup of Cremation Service of Western NY in Irondequoit, New York, explains why cost transparency is essential and how the right questions can prevent
More news about: HelloNation
May 25, 2026, 14:43 ET LG QNED73 e Soundbars trazem experiência de estádio para dentro de casa
próprios da tela. A LG solucionou essa limitação com o WOW Orchestra, tecnologia exclusiva da marca. Ao conectar soundbars LG, do premium S95TR ao SH5A e S40T, à Smart TV QNED73, os dois hardwares passam a atuar em dueto, transformando os alto-falantes da TV em canais de áudio adicionais.Isso significa
More news about: LG Electronics Brasil